Executive Overview
Total Addressable Market $770M – $1.2B Israeli scientific equipment (annual)
Portfolio Brands 16 3 Flagship • 5 Core • 8 Secondary
Competitive Threats 5 2 Critical • 3 High
M&A Targets 5 ₪37-60M potential revenue (3yr)
Pillar 1: Consumables
Recurring revenue via reagent/consumable distribution
Market size $150–250M/year
Primary target ENCO Scientific (acquire)
Margin uplift 25-40% (vs 20-30% equipment)
Pillar 2: Digital Integration
LIMS partnerships for end-to-end lab solutions
Partner #1 STARLIMS (pharma QC)
Partner #2 Benchling (biotech R&D)
Partner #3 Labguru (academic starter)
Pillar 3: Emerging Markets
FoodTech + Cannabis high-growth sectors
FoodTech targets 5 companies
Cannabis targets 3 companies
Key contact Panaxia (named buyer)
Competitive Threat Matrix
Critical Agilent, Waters Differentiate on local service
High Rhenium Bio, Bruker, ZEISS Defend through relationships
Medium Sartorius, Merck, Bio-Rad Monitor & partner where complementary
Low MRC Lab, Hollandia Maintain premium positioning
Priority Opportunities
Weizmann Institute Reconstruction
Post-June 2025 missile strike. Life sciences + chemistry buildings destroyed.
National AI Supercomputer Initiative
Supporting analytical infrastructure demand
Growing Biotech Sector
900+ biotech/LS companies, 140 scientists per 10K employees
Revenue Growth Roadmap (3-Year Horizon)
Consumables
$5-15M
LIMS Digital
$2-4M
Emerging Markets
$3-8M
New Principals
₪37-60M
Total Potential
$25-45M+